In Vivo Mononuclear Cell Tracking Using Superparamagnetic Particles of Iron Oxide

Author:

Richards Jennifer M.J.1,Shaw Catherine A.1,Lang Ninian N.1,Williams Michelle C.1,Semple Scott I.K.1,MacGillivray Thomas J.1,Gray Calum1,Crawford Julie H.1,Alam Shirjel R.1,Atkinson Anne P.M.1,Forrest Elaine K.1,Bienek Carol1,Mills Nicholas L.1,Burdess Anne1,Dhaliwal Kev1,Simpson A. John1,Wallace William A.1,Hill Adam T.1,Roddie P. Huw1,McKillop Graham1,Connolly Thomas A.1,Feuerstein Giora Z.1,Barclay G. Robin1,Turner Marc L.1,Newby David E.1

Affiliation:

1. From the Centre of Cardiovascular Science (J.M.J.R., C.A.S., N.N.L., M.C.W., S.R.A., N.L.M., A.B., D.E.N.), Clinical Research Imaging Centre (J.M.J.R., M.C.W., S.I.K.S., T.J.M., C.G., G.M., D.E.N.), Centre for Regenerative Medicine (J.H.C., G.R.B., M.L.T.), Centre for Inflammation Research, University of Edinburgh (K.D., A.J.S.), and Department of Pathology (W.A.W.), University of Edinburgh, Edinburgh; Scottish National Blood Transfusion Service Cell Therapy Research Group, Edinburgh (J.H.C., G.R.B....

Abstract

Background— Cell therapy is an emerging and exciting novel treatment option for cardiovascular disease that relies on the delivery of functional cells to their target site. Monitoring and tracking cells to ensure tissue delivery and engraftment is a critical step in establishing clinical and therapeutic efficacy. The study aims were (1) to develop a Good Manufacturing Practice–compliant method of labeling competent peripheral blood mononuclear cells with superparamagnetic particles of iron oxide (SPIO), and (2) to evaluate its potential for magnetic resonance cell tracking in humans. Methods and Results— Peripheral blood mononuclear cells 1–5×10 9 were labeled with SPIO. SPIO-labeled cells had similar in vitro viability, migratory capacity, and pattern of cytokine release to unlabeled cells. After intramuscular administration, up to 10 8 SPIO-labeled cells were readily identifiable in vivo for at least 7 days using magnetic resonance imaging scanning. Using a phased-dosing study, we demonstrated that systemic delivery of up to 10 9 SPIO-labeled cells in humans is safe, and cells accumulating in the reticuloendothelial system were detectable on clinical magnetic resonance imaging. In a healthy volunteer model, a focus of cutaneous inflammation was induced in the thigh by intradermal injection of tuberculin. Intravenously delivered SPIO-labeled cells tracked to the inflamed skin and were detectable on magnetic resonance imaging. Prussian blue staining of skin biopsies confirmed iron-laden cells in the inflamed skin. Conclusions— Human peripheral blood mononuclear cells can be labeled with SPIO without affecting their viability or function. SPIO labeling for magnetic resonance cell tracking is a safe and feasible technique that has major potential for a range of cardiovascular applications including monitoring of cell therapies and tracking of inflammatory cells. Clinical Trial Registration— URL: http://www.clinicaltrials.gov ; Unique identifier: NCT00972946, NCT01169935.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3